NewEdge Advisors’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

NewEdge Advisors’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,300	Closed	-$559	–	3688
2023 Q1	$559	Hold	4,300	–	–	﹤0.01%	3228
2022 Q4	$1	Buy	+4,300	New	+$1.8K	﹤0.01%	4068

Other funds holding PLXP

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return

NewEdge Advisors's PLXP Position: Q2 2023 in Review

NewEdge Advisors sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2023, closing a stake of 4,300 shares — an estimated $559 sold.

NewEdge Advisors first reported a position in PLXP in Q4 2022 and held it in 2 quarters. The position peaked at $559 in Q1 2023. 4 funds tracked by Wall St. Rank hold PLXP as of Q2 2023.

NewEdge Advisors reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
NewEdge Advisors sold 4,300 PLx Pharma Inc. Common Stock shares in Q2 2023, an estimated $559.
NewEdge Advisors first reported a position in PLx Pharma Inc. Common Stock in Q4 2022 and held it in 2 quarters.
NewEdge Advisors's PLx Pharma Inc. Common Stock position peaked at $559 in Q1 2023.
4 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2023.

Based on NewEdge Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.